Investing.com - Akouos reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Akouos announced earnings per share of $-0.54 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.64 on revenue of $0.00.
Akouos 's are down 45% and is trading at $13.39 , still down 1.54% from its 52 week high of $13.60 set on Thursday, November 10, 2022.
Akouos follows other major Healthcare sector earnings this month
Akouos's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar